AU2001294943A1 - Nucleic acid sequences differentially expressed in cancer tissue - Google Patents
Nucleic acid sequences differentially expressed in cancer tissueInfo
- Publication number
- AU2001294943A1 AU2001294943A1 AU2001294943A AU9494301A AU2001294943A1 AU 2001294943 A1 AU2001294943 A1 AU 2001294943A1 AU 2001294943 A AU2001294943 A AU 2001294943A AU 9494301 A AU9494301 A AU 9494301A AU 2001294943 A1 AU2001294943 A1 AU 2001294943A1
- Authority
- AU
- Australia
- Prior art keywords
- nucleic acid
- acid sequences
- differentially expressed
- cancer tissue
- sequences differentially
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57419—Specifically defined cancers of colon
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
- A01K2217/00—Genetically modified animals
- A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2500/00—Screening for compounds of potential therapeutic value
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Physics & Mathematics (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- Oncology (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Cell Biology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biophysics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US23727100P | 2000-10-02 | 2000-10-02 | |
| US60/237,271 | 2000-10-02 | ||
| PCT/US2001/030732 WO2002029086A2 (en) | 2000-10-02 | 2001-10-02 | Nucleic acid sequences differentially expressed in cancer tissue |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001294943A1 true AU2001294943A1 (en) | 2002-04-15 |
Family
ID=22893028
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001294943A Abandoned AU2001294943A1 (en) | 2000-10-02 | 2001-10-02 | Nucleic acid sequences differentially expressed in cancer tissue |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US20040110668A1 (en) |
| EP (1) | EP1330543A4 (en) |
| JP (2) | JP2004528810A (en) |
| AU (1) | AU2001294943A1 (en) |
| WO (1) | WO2002029086A2 (en) |
Families Citing this family (29)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7258973B2 (en) | 1998-08-31 | 2007-08-21 | Mayo Foundation For Medical Education & Research | Method for detecting a differentially expressed sequence |
| EP1666491A1 (en) * | 2000-06-02 | 2006-06-07 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| AU2002318112B2 (en) | 2001-04-10 | 2007-12-06 | Agensys, Inc. | Nucleic acids and corresponding proteins useful in the detection and treatment of various cancers |
| EP2325335A3 (en) * | 2001-09-14 | 2012-01-25 | Clinical Genomics Pty. Ltd | Nucleic acid markers for use in determining predisposition to neoplasm and/or adenoma |
| US7449548B2 (en) | 2001-12-07 | 2008-11-11 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 193P1E1B useful in treatment and detection of cancer |
| EP2275118A3 (en) | 2002-05-29 | 2011-10-19 | DeveloGen Aktiengesellschaft | Pancreas-specific proteins |
| AU2003276494A1 (en) * | 2002-06-13 | 2004-01-23 | Regulome Corporation | Functional sites |
| WO2004016733A2 (en) | 2002-08-16 | 2004-02-26 | Agensys, Inc. | Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer |
| US7393950B2 (en) * | 2002-08-29 | 2008-07-01 | Hong Kong University Of Science & Technology | Antisense oligonucleotides targeted to human CDC45 |
| EP1599498A2 (en) * | 2003-03-03 | 2005-11-30 | Genentech, Inc. | Compositions and methods for the treatment of systemic lupus erythematosis |
| WO2005017102A2 (en) * | 2003-05-30 | 2005-02-24 | Diadexus, Inc. | Compositions, splice variants and methods relating to ovarian specific nucleic acids and proteins |
| DE10332854A1 (en) * | 2003-07-18 | 2005-02-17 | Universitätsklinikum der Charité der Humboldt-Universität zu Berlin | Use of the newly identified human gene 7a5 / prognostin for tumor diagnostics and tumor therapy |
| ATE528397T1 (en) | 2003-08-08 | 2011-10-15 | Perseus Proteomics Inc | GENE OVEREXPRESSED IN CANCER |
| US20050186577A1 (en) | 2004-02-20 | 2005-08-25 | Yixin Wang | Breast cancer prognostics |
| US20060134653A1 (en) * | 2004-07-28 | 2006-06-22 | Bayer Healthcare Llc | Differential expression of genes in microsatellite instability |
| US8535914B2 (en) * | 2005-01-21 | 2013-09-17 | Canon Kabushiki Kaisha | Probe, probe set and information acquisition method using the same |
| FR2919063B1 (en) * | 2007-07-19 | 2009-10-02 | Biomerieux Sa | METHOD OF DETERMINING LEUCOCYTE ELASTASE INHIBITOR FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER. |
| FR2919061B1 (en) * | 2007-07-19 | 2009-10-02 | Biomerieux Sa | METHOD OF DOSING PLASTINE-I FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER. |
| FR2919062B1 (en) * | 2007-07-19 | 2009-10-02 | Biomerieux Sa | METHOD OF DETERMINING AMINOACYLASE 1 FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER. |
| ES2565512T3 (en) * | 2007-07-19 | 2016-04-05 | bioMérieux | Test procedure for liver fatty acid binding protein, ACE and CA19-9 for in vitro diagnosis of colorectal cancer |
| FR2919060B1 (en) * | 2007-07-19 | 2012-11-30 | Biomerieux Sa | METHOD OF DETERMINING EZRINE FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER |
| FR2919064B1 (en) * | 2007-07-19 | 2009-10-02 | Biomerieux Sa | METHOD OF ASSAYING APOLIPOPROTEIN ALL FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER |
| FR2919065B1 (en) * | 2007-07-19 | 2009-10-02 | Biomerieux Sa | METHOD FOR DETERMINING APOLIPOPROTEIN AI FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER |
| FR2933773B1 (en) | 2008-07-10 | 2013-02-15 | Biomerieux Sa | METHOD FOR DETERMINING THE ISOMERASE DISULFIDE PROTEIN FOR IN VITRO DIAGNOSIS OF COLORECTAL CANCER |
| WO2010135786A1 (en) * | 2009-05-29 | 2010-12-02 | Clinical Genomics Pty. Ltd. | A method for diagnosing neoplasms and molecules for use therein |
| AU2015200751B2 (en) * | 2010-03-19 | 2016-11-10 | Immatics Biotechnologies Gmbh | Novel immunotherapy against several tumors including gastrointestinal and gastric cancer |
| GB201004551D0 (en) | 2010-03-19 | 2010-05-05 | Immatics Biotechnologies Gmbh | NOvel immunotherapy against several tumors including gastrointestinal and gastric cancer |
| US11136583B2 (en) | 2017-01-10 | 2021-10-05 | Mayo Foundation For Medical Education And Research | Methods and materials for treating cancer |
| JP6702932B2 (en) * | 2017-12-27 | 2020-06-03 | 富士フイルム株式会社 | Cell imaging control device, method and program |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2135194A1 (en) * | 1992-05-22 | 1993-12-09 | Charles L. Bevins | Gastrointestinal defensins, cdna sequences and method for the production and use thereof |
| US5861494A (en) * | 1995-06-06 | 1999-01-19 | Human Genome Sciences, Inc. | Colon specific gene and protein |
| US6171816B1 (en) * | 1996-08-23 | 2001-01-09 | Human Genome Sciences, Inc. | Human XAG-1 polynucleotides and polypeptides |
| US5837841A (en) * | 1996-10-11 | 1998-11-17 | Incyte Pharmaceuticals, Inc. | Human Reg protein |
| WO1998041627A1 (en) * | 1997-03-19 | 1998-09-24 | Zymogenetics, Inc. | Secreted polypeptides with homology to xenopus cement gland proteins |
| AU8921598A (en) * | 1997-08-29 | 1999-03-16 | Human Genome Sciences, Inc. | 29 human secreted proteins |
| AU1726199A (en) * | 1997-12-31 | 1999-07-19 | Chiron Corporation | Metastatic cancer regulated gene |
| US5929033A (en) * | 1998-02-10 | 1999-07-27 | Incyte Pharmaceuticals, Inc. | Extracellular mucous matrix glycoprotein |
| DE19817946A1 (en) * | 1998-04-17 | 1999-10-21 | Metagen Gesellschaft Fuer Genomforschung Mbh | New nucleic acid sequences expressed in normal uterine tissues, and derived polypeptides, for treatment of uterine cancer and identification of therapeutic agents |
| US6262333B1 (en) * | 1998-06-10 | 2001-07-17 | Bayer Corporation | Human genes and gene expression products |
| EP1108021A2 (en) * | 1998-08-31 | 2001-06-20 | Bayer Corporation | Human genes differentially expressed in colorectal cancer |
| EP1144632A3 (en) * | 1998-12-23 | 2001-11-07 | Corixa Corporation | Compounds for immunotherapy and diagnosis of colon cancer and methods for their use |
| EP1265582A2 (en) * | 1999-09-29 | 2002-12-18 | Human Genome Sciences, Inc. | Colon and colon cancer associated polynucleotides and polypeptides |
| AU4592601A (en) * | 2000-03-21 | 2001-10-03 | Millennium Predictive Medicine | Novel genes, compositions, kits, and method for identification, assessment, prevention, and therapy of ovarian cancer |
-
2001
- 2001-10-02 US US09/969,034 patent/US20040110668A1/en not_active Abandoned
- 2001-10-02 EP EP01975643A patent/EP1330543A4/en not_active Withdrawn
- 2001-10-02 AU AU2001294943A patent/AU2001294943A1/en not_active Abandoned
- 2001-10-02 WO PCT/US2001/030732 patent/WO2002029086A2/en not_active Ceased
- 2001-10-02 JP JP2002532655A patent/JP2004528810A/en active Pending
-
2005
- 2005-07-26 US US11/190,172 patent/US20060179496A1/en not_active Abandoned
-
2007
- 2007-06-06 JP JP2007150552A patent/JP2007289196A/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| JP2004528810A (en) | 2004-09-24 |
| WO2002029086A2 (en) | 2002-04-11 |
| EP1330543A4 (en) | 2006-03-29 |
| US20040110668A1 (en) | 2004-06-10 |
| WO2002029086A3 (en) | 2002-10-03 |
| EP1330543A2 (en) | 2003-07-30 |
| US20060179496A1 (en) | 2006-08-10 |
| JP2007289196A (en) | 2007-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001294943A1 (en) | Nucleic acid sequences differentially expressed in cancer tissue | |
| AU7680300A (en) | Human dna sequences | |
| AU2002211313A1 (en) | Gene expression profiles in liver cancer | |
| AU2001295732A1 (en) | Concatenated nucleic acid sequences | |
| AU3316600A (en) | Gene expression in bladder tumors | |
| AU2002352799A1 (en) | Methods for evaluating drug-resistance gene expression in the cancer patient | |
| AU5691699A (en) | Human genes differentially expressed in colorectal cancer | |
| AU2002218269A1 (en) | Proteins and dna sequences underlying these proteins used for treating inflammations | |
| AU2001266225A1 (en) | Decondensation of dna | |
| AU2002341002A1 (en) | Use of phosphorothiolate polynucleotides in ligating nucleic acids | |
| AU2001242625A1 (en) | Gene sequence | |
| AU3605901A (en) | Nucleic acid sequences showing enhanced expression in benign neuroblastoma compared with acritical human neuroblastoma | |
| AU2001295841A1 (en) | Human dna sequences | |
| AU8026300A (en) | Sodd gene expression in cancer | |
| AU2001240103A1 (en) | Reproduction-specific genes | |
| AU2001264247A1 (en) | GASC1 gene | |
| AU2001292472A1 (en) | Rf connector | |
| AU2002215111A1 (en) | Ruthenium-aryl-compounds in cancer therapy | |
| AU2001285257A1 (en) | Human telomerase rna elements | |
| AU2001257427A1 (en) | Rna metabolism proteins | |
| AU2001292922A1 (en) | Nucleic acid detection | |
| AU5416700A (en) | Differentially expressed genes in prostate cancer | |
| AU2002364077A1 (en) | Gene expression profiles in stomach cancer | |
| AU2002324790A1 (en) | Transmembrane protein differentially expressed in cancer | |
| AU2001268466A1 (en) | 55p4h4: gene expressed in various cancers |